Ads
related to: lipitor pfizer astellas generic medication- Patient Coverage
Pay As Little As $10.
Search For Patient Coverage.
- Clinical Data
Clinical Trial Data For HCPs.
Learn More About Heart Failure.
- Resources
Resources For You And Your Staff.
Resources For You & Your Patients.
- Page Of Helpful Links
Review The Doctor Discussion Guide.
Heart Failure Education.
- Patient Coverage
Search results
Results From The WOW.Com Content Network
From 1996 to 2012, under the trade name Lipitor, atorvastatin became the world's best-selling medication of all time, with more than $125 billion in sales over approximately 14.5 years. [ 117 ] and $13 billion a year at its peak, [ 118 ] Lipitor alone "provided up to a quarter of Pfizer Inc.'s annual revenue for years."
L-Day is upon us. That thud you just heard was billions of dollars of Lipitor sales heading over the patent cliff. Pfizer (NYS: PFE) no longer has exclusivity on the drug as of today. We've known ...
Pfizer has been no stranger to the kind of damage that blockbuster drug patent expirations can inflict. The company's high-flying cholesterol fighter, Lipitor, has struggled since losing its ...
Lately, almost every day we've heard of a new Pfizer (NYS: PFE) strategy for hanging on to Lipitor sales after the drug faces generic competition. Discounts, co-pay cards, rebates, conversion to ...
Torcetrapib (CP-529,414, Pfizer) was a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.Its development was halted in 2006 when phase III studies showed excessive all-cause mortality in the treatment group receiving a combination of atorvastatin (Lipitor) and torcetrapib.
Drugs with sales above $5 billion in 2015 included: [3] [4] Rank Drug Trade name ... Pfizer. 8,697 4,009 4 Infliximab: ... Generic: Cholesterol: Feb-1998: Mon-20XX 74 ...